Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Recursion Pharmaceuticals Inc.

Clinical trials sponsored by Recursion Pharmaceuticals Inc., explained in plain language.

Recursion Pharmaceuticals Inc. RXRX NASDAQ

A clinical-stage biotech using AI to discover and develop drugs.

Trade on eToro (ad)

Not investment advice. Company information is shown for context only. Clinical trials frequently fail.

Trials to join now! 2 Completed 1 Terminated 3

Could a new drug tame dangerous brain blood vessel clusters?

Disease control Completed

This trial tests an experimental drug called REC-994 in adults with symptomatic cerebral cavernous malformation (CCM), a condition where clusters of abnormal blood vessels in the brain can cause bleeding, seizures, and other symptoms. Participants receive either a low or high dos…

Phase: PHASE2 • Sponsor: Recursion Pharmaceuticals Inc. • Aim: Disease control

Last updated Jun 27, 2026 14:02 UTC